Animal diseases often have significant consequences due to the unclear and time-
consuming diagnosis process. Furthermore, the emergence of new viral infections and drug …

Neutrophil extracellular traps (NETs) are essential for immune defense and have been
increasingly recognized for their role in infection and inflammation. In the context of airway …

COVID-19 is an independent risk factor for pulmonary embolism (PE). Little is known about
alteplase therapy in this patient group. A retrospective study analyzed 74 patients with PE …

Kawasaki disease (KD) is a systematic vasculitis that is often complicated by coronary artery
lesions and is a leading cause of acquired heart disease in developed countries. Previous …

Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) heavily burdens human health. Multiple …

Endothelial cell (EC) barrier dysfunction and increased adhesion of immune inflammatory
cells to ECs crucially contribute to acute lung injury (ALI). Angiotensin-converting enzyme 2 …

Clofazimine and Arbidol have both been reported to be effective in vitro SARS-CoV-2 fusion
inhibitors. Both are promising drugs that have been repurposed for the treatment of COVID …

ACE2 is the earliest receptor discovered to mediate the entry of SARS-CoV-2. In addition to
the receptor, it also participates in complex pathological and physiological processes …

COVID-19 is the syndrome caused by SARS-CoV-2 infection. Severe phenotypes seem to
be caused by a “cytokines storm” and pneumonia is one of the most important clinical …

The newly emerged variants of SARS-CoV-2 created a potential threat among societies and
highlighted one of the significant concerns in facing the pandemic. SARS-CoV-2 variants …